Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Fertility and Sterility

• Publication date

  1990-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0015-0282(16)53578-XPMID 2112489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.

  1989cited by this paper
• A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.

  1989cited by this paper
• Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin.

  1989cited by this paper
• The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).

  1989cited by this paper
• The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypooestrogenic by continuous administration of an LHRH agonist

  1988cited by this paper
• A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.

  1988cited by this paper
• Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.

  1987cited by this paper
• Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.

  1987cited by this paper
• Progestin modulation of estrogen-dependent marker protein synthesis in the endometrium.

  1985cited by this paper
• Progestin modulation of estrogen-dependent marker protein synthesis in the endometrium.

  1985cited by this paper
• Estrogen Biosynthesis in Leiomyoma and Myometrium of the Uterus

  1984cited by this paper
• Specific estradiol binding in embryonic Mullerian ducts: a potential modulator of regression in the male and female chick.

  1983cited by this paper
• Human endometrial cells in primary tissue culture: modulation of the progesterone receptor level by natural and synthetic estrogens in vitro.

  1981cited by this paper
• Estradiol and Progesterone Binding in Uterine Leiomyomata and in Normal Uterine Tissues

  1980cited by this paper
• Estradiol and Progesterone Receptors in Human Endometrium: Normal and Abnormal Menstrual Cycles and Early Pregnancy

  1980cited by this paper
• Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy.

  1980cited by this paper
• Determination of estradiol, estrone, and progesterone in serum and myometrium: correlation with the content of sex steroid receptors and 17 beta-hydroxysteroid dehydrogenase activity throughout the menstrual cycle.

  1979cited by this paper
• In Vitro Conversion of Estradiol-17β into Estrone in Normal Human Myometrium und Leiomyoma

  1978cited by this paper
• Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium.

  1978cited by this paper
• Oestrogen-induced progesterone receptor in human uterus.

  1975cited by this paper
• Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase.

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives

  2023cites this paper
• Benign gynecologic lesions

  2022cites this paper
• Relationship between thyroid disorders and uterine fibroids among reproductive-age women.

  2020cites this paper
• Effects of noncavity-distorting fibroids on endometrial gene expression and function†

  2017cites this paper
• The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis

  2015cites this paper
• Etiology, Clinical Manifestations, Evaluation and Management of Uterine Leiomyoma

  2015cites this paper
• Medical Management of Uterine Leiomyoma: A Comprehensive Review

  2015cites this paper
• Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids.

  2015cites this paper
• Imaging for uterine myomas and adenomyosis.

  2014cites this paper
• Radiological Interventions in Obstetrics and Gynaecology

  2014cites this paper
• The Medical Treatment of Uterine Fibroids

  2013cites this paper
• Benign Uterine Diseases

  2013cites this paper
• Efeito da mifepristona sobre a proliferação celular e expressão gênica de receptores de progesterona em um modelo de cultura primária de miométrio e leiomioma humanos

  2012cites this paper
• Persistent vaginal haemorrhage due to a uterine leiomyoma in a mare

  2010cites this paper
• Pesticide use and self-reported uterine leiomyomata among farm women: an analysis of the Agricultural Health Study with assessment of outcome misclassification

  2010influential citation
• Mitotic activity of smooth muscle cells of the myoma: Does hormonal stimulation have an effect on the number of mitoses?

  2010cites this paper
• CHAPTER 25 – Benign Uterine Disorders

  2009cites this paper
• Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.

  2009cites this paper
• Fibroids, Menstruation, Childbirth, and Evolution: The Fascinating Story of Uterine Blood Vessels

  2009cites this paper
• Uterine myoma: a condition amendable to medical therapy?

  2008cites this paper
• Medical treatment for uterine myomas.

  2008cites this paper
• The pathophysiology of dysfunctionaluterine bleeding

  2008cites this paper
• Levonorgestrel-releasing Intrauterine System (LNG-IUS)

  2007cites this paper
• Benign Gynecologic Lesions

  2007cites this paper
• Increased Frequency of Thyroid Nodules and Breast Fibroadenomas in Women with Uterine Fibroids

  2007cites this paper
• Leiomyomata uteri: hormonal and molecular determinants of growth.

  2007cites this paper
• Studies on leptin and leptin receptor gene expression in myometrium and uterine myomas of gnRH analogue-treated women.

  2006cites this paper
• Plasminogen Activator Inhibitor 1 Messenger RNA Expression and Molecular Evidence for del ( 7 ) ( q 22 ) in Uterine Leiomyomas 1

  2006cites this paper
• Sangrado uterino anormal (y el endocrinólogo)

  2005cites this paper
• [Drug treatments for uterine fibroma: rationale].

  2005cites this paper
• Role of GnRH agonists prior to endoscopic surgical treatment of fibroids

  2005cites this paper
• Les traitements médicamenteux du fibrome utérin: Argumentaire

  2005cites this paper
• Tissue levels of cadmium and trace elements in patients with myoma and uterine cancer

  2005cites this paper
• GnRH-antagonists in reproductive medicine

  2005cites this paper
• Endogenous urinary steroids in premenopausal women with uterine leiomyomas

  2004cites this paper
• HLA antigens and organ specific antimicrosomal antibodies in patients with autoimmune polyglandular syndromes (APS)

  2003cites this paper
• Etiology and pathogenesis of uterine leiomyomas: a review.

  2003cites this paper
• Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.

  2003cites this paper
• Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.

  2002cites this paper
• Nonsurgical treatment of uterine fibroids

  2002cites this paper
• Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue.

  2002cites this paper
• Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells.

  2002cites this paper
• An in vivo/in vitro Model to Assess Endocrine Disrupting Activity of Xenoestrogens in Uterine Leiomyoma

  2001cites this paper
• Female reproductive endocrinology at the turn of the millennium.

  2001cites this paper
• Transdermal Hormone Replacement Therapy in Postmenopausal Women With Uterine Leiomyomas

  2001cites this paper
• Different expression of estrogen receptors α and β in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment

  2001cites this paper
• Suppression of Transforming Growth Factor-P (TGFP) and TGFp Receptor Messenger Ribonucleic Acid and Protein Expression in Leiomyomata in Women Receiving Gonadotropin-Releasing Hormone Agonist Therapy*

  2001cites this paper
• Endothelial Nitric Oxide Synthase Expression in Leiomyoma and Parental Myometrium

  2000cites this paper
• Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro.

  2000cites this paper
• Effects of hormone replacement therapy on postmenopausal uterine myoma.

  2000cites this paper
• Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium.

  2000cites this paper
• Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids.

  2000cites this paper
• Miomatosis uterina, un enfoque endocrinolÛgico

  2000cites this paper
• Advances in uterine leiomyoma research: the progesterone hypothesis.

  2000cites this paper
• Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists.

  1999cites this paper
• Fibroids: pathophysiology and current medical treatment.

  1999cites this paper
• Recommandations pour la pratique clinique

  1999influential citation
• Tamoxifen and the female genital tract.

  1998cites this paper
• Leuprolide Acetate-Treated Leiomyomas Retain Their Relative Overexpression of Collagen Type I and Collagen Type III Messenger Ribonucleic Acid

  1998cites this paper
• GnRH agonists and add‐back therapy: is there a perfect combination?

  1998cites this paper
• Influence of progesterone and oestrogen on growth and morphology of a transplantable rat uterine smooth muscle tumour (SMT-Y).

  1998cites this paper
• Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid.

  1998cites this paper
• Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.

  1998cites this paper
• Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.

  1997cites this paper
• Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata.

  1997cites this paper
• Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment.

  1997cites this paper
• Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.

  1997cites this paper
• Gonadotrophin releasing hormone (GnRH) receptor and steroid receptors in human uterine leiomyoma, myometrium and endometrium.

  1997cites this paper
• Growth Factors and Cytokines in Uterine Leiomyomas

  1996cites this paper
• Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era.

  1996cites this paper
• Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.

  1996cites this paper
• Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.

  1996cites this paper
• GnRH agonists and uterine leiomyomas.

  1996cites this paper
• [Treatment of uterine fibromas].

  1996cites this paper
• Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls.

  1996cites this paper
• GnRH analogues in the treatment of uterine fibroids.

  1996cites this paper
• Estrogen receptor gene expression in human uterine leiomyomata.

  1995cites this paper
• Leuprolide Acetate Treatment and Myoma Arterial Size

  1995cites this paper
• Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.

  1995cites this paper
• Degenerative changes in myometrium simulating diffuse leiomyomatosis after treatment with gonadotrophin releasing hormone analogue.

  1995cites this paper
• Acute abdominal pain in pregnancy.

  1995cites this paper
• Sequential gonadotrophin-releasing hormone agonist/low-dose oral contraceptive treatment for leiomyomata uteri.

  1995cites this paper
• Abnormal Gene Expression in Uterine Leiomyomas

  1995cites this paper
• Leiomyoma Primary Cultures Have Elevated Transcriptional Response to Estrogen Compared With Autologous Myometrial Cultures

  1995cites this paper
• Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.

  1995cites this paper
• Estrogen and progesterone receptor content of GnRH analogue pretreated and untreated uterine leiomyomata.

  1995cites this paper
• Pathologic considerations of uterine smooth muscle tumors.

  1995cites this paper
• Progesterone: A critical role in the pathogenesis of uterine myomas

  1995cites this paper
• Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.

  1994cites this paper
• Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen.

  1994cites this paper
• Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone‐releasing hormone: Analogue depot therapy

  1994cites this paper
• Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin‐releasing hormone agonist pretreated women

  1994cites this paper
• Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy.

  1994cites this paper
• Leuprorelin

  1994cites this paper
• Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.

  1994cites this paper
• Massive uterine enlargement with necrosis: an unusual manifestation of adenomyosis.

  1994cites this paper
• Twin-twin transfusion with abrupt onset of microcephaly in the surviving recipient following spontaneous death of the donor twin.

  1993cites this paper
• GnRH analogues in the treatment of fibroids

  1993cites this paper
• The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues.

  1993cites this paper
• An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.

  1993cites this paper